Glaukos Corporation (GKOS) Tops Q1 EPS by 4c; Raises Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. VRTX
4. CHKP
5. CRWD
6. ON
7. HNGE
8. INSP
9. SPY
10. MRVL

Go back to Glaukos Corporation (GKOS) Tops Q1 EPS by 4c; Raises Outlook

Glaukos Corporation Announces First Quarter 2017 Financial Results

May 3, 2017 4:15 PM EDT

Company Raises 2017 Net Sales Guidance

SAN CLEMENTE, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, today announced financial results for the first quarter ended March 31, 2017. Key highlights include:

Achieved 55% net sales growth to $35.9 million in the first quarter of 2017, compared to $23.1 million in the first quarter of 2016. Reported net income of $0.9 million, or $0.02 per diluted share, in the first quarter of... More